We are live on ! Find out more
CNST

Constellation Pharmaceuticals, Inc.
CNST

Delisted

CNST was delisted on the 14th of July, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Constellation Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 153 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 153 → 0 (-153)

100% less funds holding in top 10

Funds holding in top 10: 9 → 0 (-9)

100% less capital invested

Capital invested by funds: $1.42B → $0 (-$1.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 153

Holders
–
Holders Change
-153
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
153
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$108M
2
BlackRock
BlackRock
New York
-$94M
3
CG
Column Group
California
-$88.8M
4
PM
Ponoi Management
California
-$63.6M
5
OPU
Omni Partners US
California
-$61.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
51
Beryl Capital Management
California
– -$4.42M -130,861 Closed
BSCM
52
Berry Street Capital Management
United Kingdom
– -$4.22M -125,000 Closed
Janus Henderson Group
53
Janus Henderson Group
United Kingdom
– -$4.16M -122,901 Closed
Bank of New York Mellon
54
Bank of New York Mellon
New York
– -$4.05M -119,720 Closed
N
55
Nuveen
North Carolina
– -$2.42M -119,496 Closed
CS
56
Credit Suisse
Switzerland
– -$3.76M -111,124 Closed
Barclays
57
Barclays
United Kingdom
– -$3.74M -110,787 Closed
KC
58
Kellner Capital
New York
– -$3.67M -108,423 Closed
SMC
59
S. Muoio & Co
New York
– -$3.55M -105,000 Closed
WAM
60
Wolverine Asset Management
Illinois
– -$3.51M -103,902 Closed
PCM
61
Prelude Capital Management
New York
– -$3.44M -101,865 Closed
Ohio Public Employees Retirement System (OPERS)
62
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$3.25M -96,000 Closed
DMK
63
David M. Knott
– -$3.11M -91,909 Closed
MAM
64
Melqart Asset Management
United Kingdom
– -$3.02M -89,400 Closed
CM
65
Caption Management
Oklahoma
– -$2.54M -75,000 Closed
M
66
Murchinson
Ontario, Canada
– -$2.54M -75,000 Closed
EPM
67
Equitec Proprietary Markets
Illinois
– -$2.33M -68,900 Closed
HA
68
Havens Advisors
New York
– -$2.3M -67,963 Closed
Marshall Wace
69
Marshall Wace
United Kingdom
– -$2.23M -66,135 Closed
GI
70
GAMCO Investors
Connecticut
– -$2.17M -64,211 Closed
AA
71
ALPS Advisors
Colorado
– -$2.13M -63,109 Closed
Dimensional Fund Advisors
72
Dimensional Fund Advisors
Texas
– -$2.11M -62,522 Closed
PCA
73
Personal Capital Advisors
California
– -$2.11M -62,380 Closed
Jennison Associates
74
Jennison Associates
New York
– -$2.09M -61,895 Closed
Bank of America
75
Bank of America
North Carolina
– -$2.04M -60,252 Closed
1 2
3
4 5

CNST Hedge Fund Activity: Q3 2021 in Review

0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q3 2021, worth a combined $0 — down 100% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of CNST and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $108M sold.

  • 0 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q3 2021, down from 153 in Q2 2021.
  • Funds reported $0 of Constellation Pharmaceuticals, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Constellation Pharmaceuticals, Inc. positions in Q3 2021 and 153 closed out, a net change of -153 holders.
  • The largest Constellation Pharmaceuticals, Inc. seller in Q3 2021 was Avoro Capital Advisors, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2021.